Please click here to download the program as pdf
| 15.15-15.45 h | Registration and welcome coffee |
| 15.45-16.00 h | Welcome and introduction |
| Michael Joannidis, Innsbruck; Austria; Marco Maggiorini, Zurich; Switzerland | |
| 16.00-18.30 h | Afternoon session: Hemodynamic goals |
| Chair: Michael Joannidis, Innsbruck; Austria; Peter Suter, Geneva; Switzerland | |
| 16.00-16.30 h | Pathophysiology of shock Richard Beale, London; UK |
| 16.30-17.00 h | "Less" invasive hemodynamic monitoring Zsolt Molnar, Szeged; Hungary |
| 17.00-17.30 h | Pulmonary artery catheter - still useful Marco Maggiorini, Zurich; Switzerland |
| 17.30-18.00 h | The right hemodynamic goals, an ongoing controversy Jukka Takala , Bern; Switzerland |
| 18.00-18.30 h | Round table discussion: How do I monitor my patient in shock? Moderation: Peter Suter, Geneva; Switzerland |
| 18.45-19.45 h | Get together snow cocktail |
| all lectures incl. 10 min discussion |
| 08.00-10.30 h | Morning session: ICU-Management |
| Chair: Richard Beale, London; UK; Michael Joannidis, Innsbruck; Austria | |
| 08.00-08.30 h | Basic requirements for intensive care units Andreas Valentin, Vienna; Austria |
| 08.30-09.00 h | How to manage ICU costs Jukka Takala , Bern; Switzerland |
| 09.00-09.30 h | Rationing in intensive care - facing an unavoidable challenge Andreas Valentin, Vienna; Austria |
| 09.30-10.00 h | Ressource allocation in intensive care medicine Christiane Druml, Vienna; Austria |
| 10.00-10.30 h | Closed perform better then open ICUs Jukka Takala , Bern; Switzerland (pro) & Richard Beale, London; UK (con) |
| 16.00-18.30 h | Afternoon session: Sepsis |
| Chair: Marco Maggiorini, Zurich; Switzerland; Peter Suter, Geneva; Switzerland | |
| 16.00-16.30 h | Surviving sepsis guidelines 2012 Jukka Takala , Bern; Switzerland |
| 16.30-17.00 h | The coagulation system in sepsis Lars Asmis, Zurich; Switzerland |
| 17.00-17.30 h | The "post-Xigris" era in sepsis therapy Richard Beale, London; UK |
| 17.30-18.00 h | What does really help in the severely septic patient? Michael Bauer, Jena; Germany |
| 18.00-18.30 h | Round table discussion: Sepsis bundles quo vadis? Moderation: Peter Suter, Geneva; Switzerland |
| 20.00 h | Speakers dinner for invited guests only |
| all lectures incl. 10 min discussion |
| 08.00-10.30 h | Morning session: Coagulation management in the ICU |
| Chair: Wilfred Druml, Vienna; Austria; Michael Joannidis, Innsbruck; Austria | |
| 08.00-08.30 h | Coagulopathy of trauma - new insights into the mechanism Michael Ganter, Zurich; Switzerland |
| 08.30-09.00 h | Coagulation diagnostics in the ICU incuding (ROTEM) Lars Asmis, Zurich; Switzerland |
| 09.00-09.30 h | The bleeding patients: algorithms and goal-directed coagulation therapy Michael Ganter, Zurich; Switzerland |
| 09.30-10.00 h | The Factor XIII and von Willebrand Factor neglect Lars Asmis, Zurich; Switzerland |
| 10.00-10.30 h | Pro-con debate: Fresh Frozen Plasma shall we still use it? Lars Asmis, Zurich; Switzerland (pro) & Michael Ganter, Zurich; Switzerland (con) |
| 16.00-18.30 h | Afternoon session: Patient safety |
| Chair: Marco Maggiorini, Zurich; Switzerland; Jukka Takala , Bern; Switzerland | |
| 16.00-16.30 h | Assessment of new and old technologies in the ICU: a must Peter Suter, Geneva; Switzerland |
| 16.30-17.00 h | Patient safety in the ICU – what we have learned Andreas Valentin, Vienna; Austria |
| 17.00-17.30 h | New professional profiles to ease shortages in ICM Peter Suter, Geneva; Switzerland |
| 17.30-18.00 h | Drug approval: lessons learned from the xigris experiance Richard Beale, London; UK |
| 18.00-18.30 h | Round table discussion: Less resources = less care, less science or less neither? Moderation: Jukka Takala , Bern; Switzerland |
| all lectures incl. 10 min discussion |
| 08.00-10.30 h | Morning session: Fluids in the ICU |
| Chair: Michael Bauer, Jena; Germany; Marco Maggiorini, Zurich; Switzerland | |
| 08.00-08.30 h | Rationale behind balanced solutions Michael Ganter, Zurich; Switzerland |
| 08.30-09.00 h | Rationale behind the use of albumin Michael Joannidis, Innsbruck; Austria |
| 09.00-09.30 h | Rationale behind the use of blood products (RBC & Platelets) Lars Asmis, Zurich; Switzerland |
| 09.30-10.00 h | Is there still a place for parenteral nutrition in the ICU? Wilfred Druml, Vienna; Austria |
| 10.00-10.30 h | Pro-con debate: Artifical colloids for the ICU patient Michael Ganter, Zurich; Switzerland (pro) & Michael Bauer, Jena; Germany (con) |
| 16.00-18.30 h | Afternoon session: Organ dysfunction in sepsis |
| Chair: Andreas Valentin, Vienna; Austria; Michael Joannidis, Innsbruck; Austria | |
| 16.00-16.30 h | Septic cardiomyopathy Richard Beale, London; UK |
| 16.30-17.00 h | Monitoring the hepatosplanchnic region: a challenge in critical care Michael Bauer, Jena; Germany |
| 17.00-17.30 h | Systems effects of AKI – the AKI as a motor of MODS Wilfred Druml, Vienna; Austria |
| 17.30-18.00 h | From cholestasis to secondary sclerosing cholangitis Michael Bauer, Jena; Germany |
| 18.00-18.30 h | Round table discussion: How do I monitor organ dysfunction in sepsis? Moderation: Marco Maggiorini, Zurich; Switzerland |
| 19.00 h | Social evening |
| all lectures incl. 10 min discussion |
| 08.00-10.30 h | Morning session: The Lung |
| Chair: Michael Joannidis, Innsbruck; Austria; Peter Suter, Geneva; Switzerland | |
| 08.00-08.30 h | The lung of the ICU patient: basic physiologic concepts Zsolt Molnar, Szeged; Hungary |
| 08.30-09.00 h | The lung as a source and target in sepsis Michael Bauer, Jena; Germany |
| 09.00-09.30 h | EVLW, a useful parameter in sepsis management? Zsolt Molnar, Szeged; Hungary |
| 09.30-10.00 h | How to estimate lung recruitment at the bedside Laurent Brochard, Geneva; Switzerland |
| 10.00-10.30 h | Pro-con debate: Do we need new ARDS criteria? Laurent Brochard, Geneva; Switzerland (pro) & Peter Suter, Geneva; Switzerland (con) |
| 16.00-19.00 h | Afternoon session: Extra-corporeal assist devices |
| Chair: Richard Beale, London; UK; Marco Maggiorini, Zurich; Switzerland | |
| 16.00-16.30 h | BIPAP /APRV: what does it mean? What is it for? Laurent Brochard, Geneva; Switzerland |
| 16.30-17.00 h | Extra-corporal cytotoxine and endotoxin removal, what can we expect? Michael Joannidis, Innsbruck; Austria |
| 17.00-17.30 h | ECMO: experience with H1N1 Laurent Brochard, Geneva; Switzerland |
| 17.30-18.00 h | ECMO for the failing heart? Marco Maggiorini, Zurich; Switzerland |
| 18.00-18.30 h | Round table discussion: Can the process for end-of-life decisions be standardized? Moderation: Andreas Valentin, Vienna; Austria |
| all lectures incl. 10 min discussion |
| 08.00-10.30 h | Morning session: Minimal invasive organ support therapy |
| Chair: Michael Joannidis, Innsbruck; Austria; Marco Maggiorini, Zurich; Switzerland | |
| 08.00-08.30 h | Noninvasive ventilation in the ICU: Most recent trends Laurent Brochard, Geneva; Switzerland |
| 08.30-09.00 h | The multiple unrecognized negative side effects of RRT Wilfred Druml, Vienna; Austria |
| 09.00-09.30 h | Therapeutic hypothermia as an organ support strategy Michael Joannidis, Innsbruck; Austria |
| 09.30-10.00 h | Extracorporeal CO2-removal, is there a clear indication? Marco Maggiorini, Zurich; Switzerland |
| 10.00-10.30 h | Pro-con debate: Endotoxin removal in sepsis? Marco Maggiorini, Zurich; Switzerland (pro) & Michael Joannidis, Innsbruck; Austria (con) |
| 10.30-10.45 h | Closing remarks |
| all lectures incl. 10 min discussion |